mPEG2-bromide is a short, monofunctional methoxy-poly(ethylene glycol) bromide reagent featuring an ether-linked PEG chain capped by a terminal bromide. Structurally, the PEG segment provides aqueous solubility and a flexible, hydrophilic spacer, while the bromide serves as a reactive handle for nucleophilic substitution or alkylation. In PROTAC linker design, such PEG–halide intermediates are commonly used to introduce polyethylene glycol spacers between the ligand-binding modules and the conjugation point, helping to tune linker length, conformational freedom, and overall physicochemical properties that influence ternary complex formation and cellular uptake. The PEG spacer can also reduce nonspecific hydrophobic interactions and improve handling in aqueous bioconjugation workflows. For targeted protein degradation research, mPEG2-bromide is valuable as a practical building block to generate PROTAC precursors with controlled hydrophilicity and defined attachment chemistry, supporting systematic linker optimization in degradation assays.
Structure of 54149-17-6
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
This mPEG2-bromide is a polyethylene glycol-based alkyl bromide designed for efficient installation of PEG handles in targeted protein degradation workflows. Its primary role in PROTAC construction is to serve as a reactive PEG linker intermediate that can be functionalized to tune solubility, reduce nonspecific interactions, and improve conjugate handling. The subsequent points describe its structure-related features and practical reactivity considerations for researchers assembling PROTACs.
Structure: The molecule consists of a short poly(ethylene glycol) chain terminated by a bromide leaving group. It contains repeating ether linkages that confer flexibility and hydrophilicity, alongside a terminal C–Br bond suitable for nucleophilic substitution. The ether-rich scaffold is typically compatible with aqueous and mixed-solvent conditions used in bioconjugation.
Reactivity: As an alkyl bromide, it undergoes nucleophilic substitution with appropriate nucleophiles to form ether or carbon–heteroatom linkages, enabling PEG installation onto PROTAC fragments. Common approaches use base-assisted substitution under anhydrous or controlled-humidity conditions, with polar aprotic solvents to promote SN-type pathways. Reaction design should consider nucleophile strength, steric accessibility, and minimizing side reactions such as elimination; catalysts are generally not required for substitution chemistry.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.